Meet Novalix at ACS Fall in Washington, DC in August 2025!
This event organized by the American Chemical Society (ACS) brings together chemists from industry, academia, and government to explore presentations spanning all chemistry disciplines, symposia, and an exhibition showcasing the latest tools.
ACS meetings enable chemistry professionals to meet to share ideas and advance scientific and technical knowledge.
Luc Van Hijfte, our Senior advisor Drug Discovery and President of the EFMC, will attend the upcoming ACS Meeting in Washington DC.
In his role as EFMC President, he will meet with the ACS MEDI Division Board to further nurture the excellent partnership between our two organizations.
Alongside Alessandro Taddei, Director Business Development, Dr Luc Van Hijfte, Senior advisor Drug Discovery and EFMC president, will represent Novalix. Bringing together deep expertise in chemistry, medicinal chemistry, pharmacology, DMPK, and biophysics, our highly integrated approach is designed to create real value for our partners.
Contact us to know more about our services, and to explore how Novalix can support your drug discovery challenges from the earliest stages to candidate selection!
Event
Visit websiteDate
From
Aug 17, 2025
to
Aug 21, 2025
Location
Washington, DC, USA
Attendees
Alessandro Taddei
Director Business Development
Dr Luc Van Hifjte
Senior advisor Drug Discovery, EFMC president